ArticleActa pharmacologica Sinica2025

LN-439A, a novel BAP1 inhibitor, suppresses the growth of basal-like breast cancer by degrading KLF5.

Tian-Tian Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.